Home/Filings/4/0001250853-18-000100
4//SEC Filing

Maynard Ryan D 4

Accession 0001250853-18-000100

CIK 0001425205other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 5:07 PM ET

Size

5.8 KB

Accession

0001250853-18-000100

Insider Transaction Report

Form 4
Period: 2018-07-17
Transactions
  • Award

    Stock Option (right to buy)

    2018-07-17+35,00035,000 total
    Exercise: $14.45Exp: 2028-07-16Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant. If the Reporting Person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service, unless the Reporting Person is terminated for cause, in which case the options shall terminate immediately.

Issuer

IOVANCE BIOTHERAPEUTICS, INC.

CIK 0001425205

Entity typeother

Related Parties

1
  • filerCIK 0001363984

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:07 PM ET
Size
5.8 KB